YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJGR6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,889
Award facts
- Contract value 100% obligated
- $1,888.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $1,888.62 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in single-dose vials, with a completion date of January 27, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded this firm fixed-price delivery order without a set-aside designation on January 5, 2026. The order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
This delivery order represents a routine pharmaceutical supply procurement within the broader PPV-G GEN V framework, which authorizes the Defense Logistics Agency to issue firm fixed-price orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's single-award IDC under PPV-G GEN V, valued at $499,999,999 with a completion date of December 31, 2036, positions the company as a critical regional pharmaceutical supplier supporting military healthcare operations. The company's extensive product portfolio and demonstrated performance across numerous prior delivery orders underscore its capability to fulfill specialized pharmaceutical requirements for federal military medical systems.
Quick answers
Who was awarded contract SPE2DR26FJGR6?
SPE2DR26FJGR6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FJGR6 worth?
The government has obligated $1,889 on SPE2DR26FJGR6.
Is contract SPE2DR26FJGR6 an order under another contract?
Yes. SPE2DR26FJGR6 is a delivery order under SPE2DR25D9150, an indefinite delivery contract.
Was contract SPE2DR26FJGR6 competed?
The extent of competition for SPE2DR26FJGR6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award